These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25459220)

  • 1. The effect of HIV infection on the host response to bacterial sepsis.
    Huson MA; Grobusch MP; van der Poll T
    Lancet Infect Dis; 2015 Jan; 15(1):95-108. PubMed ID: 25459220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV Coinfection Enhances Complement Activation During Sepsis.
    Huson MA; Wouters D; van Mierlo G; Grobusch MP; Zeerleder SS; van der Poll T
    J Infect Dis; 2015 Aug; 212(3):474-83. PubMed ID: 25657259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host innate immune responses to microbial pathogens.
    Delaloye J; Calandra T
    Curr Vasc Pharmacol; 2013 Mar; 11(2):123-32. PubMed ID: 23506491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic influence on bloodstream infections and sepsis.
    Kumpf O; Schumann RR
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 1():S44-50. PubMed ID: 18849152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sepsis predisposition in children with human immunodeficiency virus.
    Hatherill M
    Pediatr Crit Care Med; 2005 May; 6(3 Suppl):S92-8. PubMed ID: 15857567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response in burn patients in relation to HIV infection and sepsis.
    Sjöberg T; Mzezewa S; Jönsson K; Salemark L
    Burns; 2004 Nov; 30(7):670-4. PubMed ID: 15475140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune restoration disease in HIV patients: aberrant immune responses after antiretroviral therapy.
    French M; Price P
    J HIV Ther; 2002 May; 7(2):46-51. PubMed ID: 12553688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the pathophysiology of the septic host upon admission?
    Giamarellos-Bourboulis EJ
    Int J Antimicrob Agents; 2010 Dec; 36 Suppl 2():S2-5. PubMed ID: 21129934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is neuroimmunomodulation a future therapeutic approach for sepsis?
    Kumar V; Sharma A
    Int Immunopharmacol; 2010 Jan; 10(1):9-17. PubMed ID: 19840870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host-pathogen interactions in sepsis.
    van der Poll T; Opal SM
    Lancet Infect Dis; 2008 Jan; 8(1):32-43. PubMed ID: 18063412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate immunity in sepsis pathogenesis and its modulation: new immunomodulatory targets revealed.
    Kumar V; Sharma A
    J Chemother; 2008 Dec; 20(6):672-83. PubMed ID: 19129063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART.
    Aiuti F; Mezzaroma I
    AIDS Rev; 2006; 8(2):88-97. PubMed ID: 16848276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers of immune dysfunction following combination antiretroviral therapy for HIV infection.
    Lichtfuss GF; Hoy J; Rajasuriar R; Kramski M; Crowe SM; Lewin SR
    Biomark Med; 2011 Apr; 5(2):171-86. PubMed ID: 21473720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cytokines and chemokines in the regulation of innate immunity and HIV infection.
    Alfano M; Poli G
    Mol Immunol; 2005 Feb; 42(2):161-82. PubMed ID: 15488606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immune response to severe bacterial infections: consequences for therapy.
    Giamarellos-Bourboulis EJ; Raftogiannis M
    Expert Rev Anti Infect Ther; 2012 Mar; 10(3):369-80. PubMed ID: 22397569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New perspectives on immunomodulatory therapy for bacteraemia and sepsis.
    Opal SM
    Int J Antimicrob Agents; 2010 Dec; 36 Suppl 2():S70-3. PubMed ID: 21129935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining immunological dysfunction in sepsis: A requisite tool for precision medicine.
    Bermejo-Martin JF; Andaluz-Ojeda D; Almansa R; Gandía F; Gómez-Herreras JI; Gomez-Sanchez E; Heredia-Rodríguez M; Eiros JM; Kelvin DJ; Tamayo E
    J Infect; 2016 May; 72(5):525-36. PubMed ID: 26850357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in sepsis research derived from animal models.
    Männel DN
    Int J Med Microbiol; 2007 Sep; 297(5):393-400. PubMed ID: 17452126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary defense mechanisms against pneumonia and sepsis.
    Tsai KS; Grayson MH
    Curr Opin Pulm Med; 2008 May; 14(3):260-5. PubMed ID: 18427251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.